🇺🇸 DAMOCTOCOG ALFA PEGOL in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Haemarthrosis — 2 reports (18.18%)
  2. Anti-Polyethylene Glycol Antibody — 1 report (9.09%)
  3. Deep Vein Thrombosis — 1 report (9.09%)
  4. Disseminated Intravascular Coagulation — 1 report (9.09%)
  5. Drug Interaction — 1 report (9.09%)
  6. Dyspnoea — 1 report (9.09%)
  7. Gastrointestinal Haemorrhage — 1 report (9.09%)
  8. Haematoma Muscle — 1 report (9.09%)
  9. Haemorrhage — 1 report (9.09%)
  10. Muscle Haemorrhage — 1 report (9.09%)

Source database →

DAMOCTOCOG ALFA PEGOL in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DAMOCTOCOG ALFA PEGOL approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for DAMOCTOCOG ALFA PEGOL in United States?

Marketing authorisation holder not available in our data.